Cargando…

Role of magnesium sulfate in neuroprotection in acute ischemic stroke

AIMS: To study the effect of intravenous magnesium sulfate infusion on clinical outcome of patients of acute stroke. MATERIALS AND METHODS: Sixty consecutive cases of acute ischemic stroke hospitalised within 24 h of an episode of stroke were taken as subjects. All subjects underwent a computed tomo...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Harpreet, Jalodia, Sunil, Gupta, M. S., Talapatra, Paulomi, Gupta, Vikas, Singh, Ishwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424793/
https://www.ncbi.nlm.nih.gov/pubmed/22919188
http://dx.doi.org/10.4103/0972-2327.99705
_version_ 1782241259931303936
author Singh, Harpreet
Jalodia, Sunil
Gupta, M. S.
Talapatra, Paulomi
Gupta, Vikas
Singh, Ishwar
author_facet Singh, Harpreet
Jalodia, Sunil
Gupta, M. S.
Talapatra, Paulomi
Gupta, Vikas
Singh, Ishwar
author_sort Singh, Harpreet
collection PubMed
description AIMS: To study the effect of intravenous magnesium sulfate infusion on clinical outcome of patients of acute stroke. MATERIALS AND METHODS: Sixty consecutive cases of acute ischemic stroke hospitalised within 24 h of an episode of stroke were taken as subjects. All subjects underwent a computed tomography head, and those found to have evidence of bleed/space-occupying lesions were excluded from the study. The subjects taken up for the study were divided into two groups of 30 subjects each. Both the groups received the standard protocol management for acute ischemic stroke. Subjects of Group 1 additionally received intravenous magnesium sulfate as initial 4 g bolus dose over 15 min followed by 16 g as slow infusion over the next 24 h. In all the subjects of the two study groups, serum magnesium levels were estimated at the time of admission (Day 0), Day 1 and Day 2 of hospitalization using an atomic absorption spectrometer. STATISTICAL ANALYSIS USED: Scandinavian stroke scores were calculated on Day 3, day of discharge and Day 28. Paired t-test was employed for comparison of stroke scores on Day 3, day of discharge and Day 28 within the same group and the unpaired t-test was used for the intergroup comparison, i.e. comparison of stroke scores of control group with corresponding stroke scores of magnesium group. RESULTS: Comparison of stroke scores on Day 3 and day of discharge, on the day of discharge and Day 28 and on Day 3 and Day 28 in the magnesium group produced a t-value of 5.000 and P <0.001, which was highly significant. However, the comparison of the mean stroke scores between the magnesium and the control groups on Day 3, day of discharge and Day 28 yielded a P-value of >0.05, which was not significant. CONCLUSIONS: The study failed to document a statistical significant stroke recovery in spite of achieving a significant rise in serum magnesium level, more than that necessary for neuroprotection, with an intravenous magnesium sulfate regime.
format Online
Article
Text
id pubmed-3424793
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-34247932012-08-23 Role of magnesium sulfate in neuroprotection in acute ischemic stroke Singh, Harpreet Jalodia, Sunil Gupta, M. S. Talapatra, Paulomi Gupta, Vikas Singh, Ishwar Ann Indian Acad Neurol Original Article AIMS: To study the effect of intravenous magnesium sulfate infusion on clinical outcome of patients of acute stroke. MATERIALS AND METHODS: Sixty consecutive cases of acute ischemic stroke hospitalised within 24 h of an episode of stroke were taken as subjects. All subjects underwent a computed tomography head, and those found to have evidence of bleed/space-occupying lesions were excluded from the study. The subjects taken up for the study were divided into two groups of 30 subjects each. Both the groups received the standard protocol management for acute ischemic stroke. Subjects of Group 1 additionally received intravenous magnesium sulfate as initial 4 g bolus dose over 15 min followed by 16 g as slow infusion over the next 24 h. In all the subjects of the two study groups, serum magnesium levels were estimated at the time of admission (Day 0), Day 1 and Day 2 of hospitalization using an atomic absorption spectrometer. STATISTICAL ANALYSIS USED: Scandinavian stroke scores were calculated on Day 3, day of discharge and Day 28. Paired t-test was employed for comparison of stroke scores on Day 3, day of discharge and Day 28 within the same group and the unpaired t-test was used for the intergroup comparison, i.e. comparison of stroke scores of control group with corresponding stroke scores of magnesium group. RESULTS: Comparison of stroke scores on Day 3 and day of discharge, on the day of discharge and Day 28 and on Day 3 and Day 28 in the magnesium group produced a t-value of 5.000 and P <0.001, which was highly significant. However, the comparison of the mean stroke scores between the magnesium and the control groups on Day 3, day of discharge and Day 28 yielded a P-value of >0.05, which was not significant. CONCLUSIONS: The study failed to document a statistical significant stroke recovery in spite of achieving a significant rise in serum magnesium level, more than that necessary for neuroprotection, with an intravenous magnesium sulfate regime. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3424793/ /pubmed/22919188 http://dx.doi.org/10.4103/0972-2327.99705 Text en Copyright: © Annals of Indian Academy of Neurology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Singh, Harpreet
Jalodia, Sunil
Gupta, M. S.
Talapatra, Paulomi
Gupta, Vikas
Singh, Ishwar
Role of magnesium sulfate in neuroprotection in acute ischemic stroke
title Role of magnesium sulfate in neuroprotection in acute ischemic stroke
title_full Role of magnesium sulfate in neuroprotection in acute ischemic stroke
title_fullStr Role of magnesium sulfate in neuroprotection in acute ischemic stroke
title_full_unstemmed Role of magnesium sulfate in neuroprotection in acute ischemic stroke
title_short Role of magnesium sulfate in neuroprotection in acute ischemic stroke
title_sort role of magnesium sulfate in neuroprotection in acute ischemic stroke
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424793/
https://www.ncbi.nlm.nih.gov/pubmed/22919188
http://dx.doi.org/10.4103/0972-2327.99705
work_keys_str_mv AT singhharpreet roleofmagnesiumsulfateinneuroprotectioninacuteischemicstroke
AT jalodiasunil roleofmagnesiumsulfateinneuroprotectioninacuteischemicstroke
AT guptams roleofmagnesiumsulfateinneuroprotectioninacuteischemicstroke
AT talapatrapaulomi roleofmagnesiumsulfateinneuroprotectioninacuteischemicstroke
AT guptavikas roleofmagnesiumsulfateinneuroprotectioninacuteischemicstroke
AT singhishwar roleofmagnesiumsulfateinneuroprotectioninacuteischemicstroke